Results 1 to 10 of about 2,319,540 (269)

Application of Janus Particles in Point-of-Care Testing

open access: yesBiosensors, 2022
Janus particles (JPs), named after the two-faced Roman god, are asymmetric particles with different chemical properties or polarities. JPs have been widely used in the biomedical field in recent years, including as drug carriers for targeted controlled ...
Yuhan Wang   +6 more
doaj   +1 more source

Liquid Crystal Droplet-Based Biosensors: Promising for Point-of-Care Testing

open access: yesBiosensors, 2022
The development of biosensing platforms has been impressively accelerated by advancements in liquid crystal (LC) technology. High response rate, easy operation, and good stability of the LC droplet-based biosensors are all benefits of the long-range ...
Ruwen Xie   +7 more
doaj   +1 more source

Differences in EEG Event-Related Potentials during Dual Task in Parkinson’s Disease Carriers and Non-Carriers of the G2019S-LRRK2 Mutation

open access: yesSensors, 2023
Background: The G2019S-LRRK2 gene mutation is a common cause of hereditary Parkinson’s disease (PD), associated with a higher frequency of the postural instability gait difficulty (PIGD) motor phenotype yet with preserved cognition.
Eden Shkury   +6 more
doaj   +1 more source

Plasma Extracellular Vesicle Size and Concentration Are Altered in Alzheimer’s Disease, Dementia With Lewy Bodies, and Frontotemporal Dementia

open access: yesFrontiers in Cell and Developmental Biology, 2021
Alzheimer’s disease (AD), frontotemporal dementia (FTD), and dementia with Lewy bodies (DLB) are the three major neurodegenerative dementias. In this study, we provide evidence that an alteration in extracellular vesicles (EVs) release is common across ...
Antonio Longobardi   +12 more
doaj   +1 more source

Marker-of-self becomes marker-of-senescence [PDF]

open access: yesBlood, 2012
In this issue of Blood , Burger et al provide compelling in vitro evidence that phagocytic uptake of aged human erythrocytes is promoted by the marker of self CD47 in complex with the serum factor thrombospondin-1.[1][1] CD47 is expressed on cells of all types and binds and signals to SIRPα ...
Nisha, Sosale, Dennis E, Discher
openaire   +2 more sources

What Makes a Marker a Good Marker? [PDF]

open access: yesBrain, Behavior and Evolution, 2014
To validate if DCX truly predicts neuron recruitment throughout the canary brain, it should correlate to a high degree with established methods for studying neuron recruitment, such as labeling cells with the mitotic marker 5-bromo-2-deoxyuridine (BrdU).
Vellema, M.   +3 more
openaire   +2 more sources

Handling Marker-Marker Linkage Disequilibrium: Pedigree Analysis with Clustered Markers [PDF]

open access: yesThe American Journal of Human Genetics, 2005
Single-nucleotide polymorphisms (SNPs) are rapidly replacing microsatellites as the markers of choice for genetic linkage studies and many other studies of human pedigrees. Here, we describe an efficient approach for modeling linkage disequilibrium (LD) between markers during multipoint analysis of human pedigrees.
Abecasis, Gonçalo R.   +1 more
openaire   +2 more sources

Circulating Tumor Cell PD-L1 Expression as Biomarker for Therapeutic Efficacy of Immune Checkpoint Inhibition in NSCLC

open access: yesCells, 2019
Over the last decade, the immune checkpoint blockade targeting the programmed death protein 1 (PD-1)/programmed death ligand 1 (PD-L1) axis has improved progression-free and overall survival of advanced non-small cell lung cancer (NSCLC) patients.
Vera Kloten   +3 more
doaj   +1 more source

N-Terminally Truncated and Pyroglutamate-Modified Aβ Forms Are Measurable in Human Cerebrospinal Fluid and Are Potential Markers of Disease Progression in Alzheimer’s Disease

open access: yesFrontiers in Neuroscience, 2021
Alzheimer’s disease (AD) is a pathology characterized by the accumulation in the brain of intracellular and extracellular amyloid-β (Aβ) aggregates, especially of Aβ1–40 and Aβ1–42 peptides.
Guido Domingo   +11 more
doaj   +1 more source

Molecular Pathways Bridging Frontotemporal Lobar Degeneration and Psychiatric Disorders

open access: yesFrontiers in Aging Neuroscience, 2016
The overlap of symptoms between neurodegenerative and psychiatric diseases has been reported. Neuropsychiatric alterations are commonly observed in dementia, especially in the behavioral variant of frontotemporal dementia (bvFTD), which is the most ...
Roberta eZanardini   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy